Zuckerberg Sued Over Privacy Scandals, Alleged Insider Trades (1) (Bloomberg)
Mark Zuckerberg and Facebook Inc.‘s other top executives have been hit with a lawsuit accusing them of insider trading and blaming them for the privacy scandals that have rocked the social media giant and its stock value since 2016. The shareholder complaint was filed May 1 in Delaware Chancery Court against Zuckerberg, Sheryl Sandberg, Peter Thiel, and three other Facebook board members. It comes about a week after the company announced it expected to pay a fine of up to $5 billion for violating a Federal Trade Commission consent decree requiring better privacy safeguards.
Wednesday 5/1 Insider Buying Report: GRUB, CERN (Nasdaq.com)
On Tuesday, GrubHub (GRUB)’s CEO, Matthew M. Maloney, made a $999,982 purchase of GRUB, buying 15,416 shares at a cost of $64.87 a piece. So far Maloney is in the green, up about 9.2% on their buy based on today’s trading high of $70.85. GrubHub is trading up about 4.9% on the day Wednesday. This buy marks the first one filed by Maloney in the past twelve months. And at Cerner Corp. (CERN), there was insider buying on Tuesday, by Director R. Halsey Wise who purchased 7,600 shares at a cost of $65.76 each, for a total investment of $499,776. Cerner Corp. is trading up about 0.2% on the day Wednesday. So far Wise is in the green, up about 2.1% on their buy based on today’s trading high of $67.11.
SEC Obtains Asset Freeze in Connection with Alleged Insider Trading (HedgeCo.net)
(HedgeCo.Net) The Securities and Exchange Commission has announced the entry of an emergency court order freezing assets related to alleged insider trading that yielded approximately $2.5 million in profits in connection with the April 12, 2019 announcement that oil-and-gas conglomerate Chevron Corporation intended to acquire Anadarko Petroleum Corporation. The SEC’s complaint, which was filed in U.S. District Court for the Southern District of New York, identifies a series of suspicious transactions prior to the announcement that Chevron intends to acquire all of Anadarko’s outstanding shares for $65 per share in cash and stock, representing a 38 percent premium over Anadarko’s pre-announcement closing price.
Edwards Lifesciences Corp (EW) Chairman & CEO Michael A Mussallem Sold $5.7 million of Shares (GuruFocus)
Chairman & CEO of Edwards Lifesciences Corp (NYSE:EW) Michael A Mussallem sold 32,800 shares of EW on 04/29/2019 at an average price of $174.73 a share. The total sale was $5.7 million. Edwards Lifesciences Corp is a part of the healthcare sector. The company specializes in the treatment of structural heart disease. It manufactures heart valves and repair products used to replace or repair a patient’s diseased or defective heart valve. Edwards Lifesciences Corp has a market cap of $36.71 billion; its shares were traded at around $176.07 with a P/E ratio of 49.07 and P/S ratio of 9.81. Edwards Lifesciences Corp had annual average EBITDA growth of 17.70% over the past ten years. GuruFocus rated Edwards Lifesciences Corp the business predictability rank of 4-star.
The CFO, Executive VP – Fin of Raymond James Financial (NYSE: RJF) is Selling Shares (Analyst Ratings)
Today, the CFO, Executive VP – Fin of Raymond James Financial (RJF), Jeffrey Julien, sold shares of RJF for $2.55M. This is Julien’s first Sell trade following 5 Buy transactions. Following Jeffrey Julien’s last RJF Sell transaction on April 26, 2019, the stock climbed by 1.8%. Based on Raymond James Financial’s latest earnings report for the quarter ending March 31, the company posted quarterly revenue of $1.93 billion and quarterly net profit of $261 million. In comparison, last year the company earned revenue of $1.84 billion and had a net profit of $242 million. RJF’s market cap is $12.88B and the company has a P/E ratio of 13.45. Currently, Raymond James Financial has an average volume of 910.8K.
